Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01775540 · ClinicalTrials.gov registry record · NA
Systane Ultra Versus Maxidex Versus Saline
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT01775540 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 36 participants.
The verdict
NCT01775540, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This study was to evaluate the healing action on the eye surface of the artificial tear Systane® ULTRA as compared to two other eyedrops: Maxidex and Saline solution. Dry eye disease leads to inflammation of the eye surface and treating dry eyes with artificial tears may lead to reduction in this inflammation and improvement of symptoms and signs.
Interventions
- DRUG Saline solution
- DRUG Systane Ultra
- DRUG Maxidex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01775540
The ClinicalTrials.gov registry entry for NCT01775540 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Saline solution is the first listed.
NCT01775540 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01775540 about?
NCT01775540 is a clinical study titled "Systane Ultra Versus Maxidex Versus Saline". This study was to evaluate the healing action on the eye surface of the artificial tear Systane® ULTRA as compared to two other eyedrops: Maxidex and Saline solution. Dry eye disease leads to inflammation of the eye surface and treating dry eyes with artificial tears may lead to reduction in this in...
What is the current status of trial NCT01775540?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2012-05. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01775540?
The interventions under investigation include: Saline solution (DRUG), Systane Ultra (DRUG), Maxidex (DRUG).
Who is sponsoring clinical trial NCT01775540?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.